Antiphospholipid antibodies increase the levels of mitochondrial DNA in placental extracellular vesicles: Alarmin-g for preeclampsia

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Tong, Mancy ^a   Johansson, Caroline ^a,b   Xiao, Fengyi ^a,c   Stone, Peter R ^a   James, Joanna L ^a   Chen, Qi ^a   Cree, Lynsey M ^a   Chamley, Lawrence W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LINKÖPING UNIVERSITY   (Sweden)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; MITOCHONDRIAL DNA; PHOSPHOLIPID ANTIBODY;

CELL LINE; DRUG EFFECT; EXOSOME; FEMALE; GENETICS; HUMAN; METABOLISM; PLACENTA; PREECLAMPSIA; PREGNANCY; WESTERN BLOTTING;

ALARMINS; ANTIBODIES, ANTIPHOSPHOLIPID; BLOTTING, WESTERN; CELL LINE; DNA, MITOCHONDRIAL; EXTRACELLULAR VESICLES; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 85036532876     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-16448-5     Document Type: Article

References (73)

1. Roberts, J. M. & Hubel, C. A. The two stage model of preeclampsia: variations on the theme. Placenta 30 Suppl A, S32-37, https:// doi.org/10.1016/j.placenta.2008.11.009 (2009).
2. Redman, C. W., Sacks, G. P. & Sargent, I. L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. American journal of obstetrics and gynecology 180, 499-506 (1999).
3. Tong, M. & Chamley, L. W. Placental extracellular vesicles and feto-maternal communication. Cold Spring Harbor perspectives in medicine 5, a023028, https://doi.org/10.1101/cshperspect.a023028 (2015).
4. Tong, M. et al. Proteomic characterization of macro-, micro-and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Human reproduction 31, 687-699, https://doi.org/10.1093/humrep/dew004 (2016).
5. Sarker, S. et al. Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. Journal of translational medicine 12, 204, https://doi.org/10.1186/1479-5876-12-204 (2014).
6. Salomon, C. et al. A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PloS one 9, e98667, https://doi.org/10.1371/journal.pone.0098667 (2014).
7. Southcombe, J., Tannetta, D., Redman, C. & Sargent, I. The immunomodulatory role of syncytiotrophoblast microvesicles. PloS one 6, e20245, https://doi.org/10.1371/journal.pone.0020245 (2011).
8. Pap, E. et al. T lymphocytes are targets for platelet-and trophoblast-derived microvesicles during pregnancy. Placenta 29, 826-832, https://doi.org/10.1016/j.placenta.2008.06.006 (2008).
9. Thibault, G. et al. The inhibitory effect of human syncytiotrophoblast plasma membrane vesicles on in vitro lymphocyte proliferation is associated with reduced interleukin 2 receptor expression. Cellular immunology 138, 165-174 (1991).
10. Aly, A. S. et al. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. American journal of obstetrics and gynecology 190, 252-258, https://doi.org/10.1016/j.ajog.2003.07.003 (2004).
11. Tannetta, D. S. et al. Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function. PloS one 10, e0142538, https://doi.org/10.1371/journal.pone.0142538 (2015).
12. Abumaree, M. H., Stone, P. R. & Chamley, L. W. The effects of apoptotic, deported human placental trophoblast on macrophages: possible consequences for pregnancy. Journal of reproductive immunology 72, 33-45, https://doi.org/10.1016/j.jri.2006.03.001 (2006).
13. Chen, Q., Stone, P. R., McCowan, L. M. & Chamley, L. W. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension 47, 116-121, https://doi.org/10.1161/01.HYP.0000196731.56062.7c (2006).
14. Goswami, D. et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27, 56-61, https://doi.org/10.1016/j.placenta.2004.11.007 (2006).
15. Tannetta, D. S., Dragovic, R. A., Gardiner, C., Redman, C. W. & Sargent, I. L. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PloS one 8, e56754, https://doi.org/10.1371/journal. pone.0056754 (2013).
16. Lok, C. A. et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertension in pregnancy: official journal of the International Society for the Study of Hypertension in Pregnancy 27, 344-360, https://doi. org/10.1080/10641950801955733 (2008).
17. Chen, Y., Huang, Y., Jiang, R. & Teng, Y. Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 119, 234-238, https://doi.org/10.1016/j.ijgo.2012.07.010 (2012).
18. Attwood, H. D. & Park, W. W. Embolism to the lungs by trophoblast. The Journal of obstetrics and gynaecology of the British Commonwealth 68, 611-617 (1961).
19. McIntyre, J. A., Wagenknecht, D. R. & Sugi, T. Phospholipid binding plasma proteins required for antiphospholipid antibody detection-an overview. American journal of reproductive immunology 37, 101-110 (1997).
20. Lockwood, C. J. et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American journal of obstetrics and gynecology 161, 369-373, doi:0002-9378(89)90522-X [pii] (1989).
21. Pattison, N. S., Chamley, L. W., McKay, E. J., Liggins, G. C. & Butler, W. S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. British journal of obstetrics and gynaecology 100, 909-913 (1993).
22. Duckitt, K. & Harrington, D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Bmj 330, 565, https://doi.org/10.1136/bmj.38380.674340.E0 (2005).
23. Pantham, P. et al. Antiphospholipid antibodies bind syncytiotrophoblast mitochondria and alter the proteome of extruded syncytial nuclear aggregates. Placenta, https://doi.org/10.1016/j.placenta.2015.10.006 (2015).
24. Viall, C. A. et al. Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. Journal of autoimmunity 47, 45-57, https://doi.org/10.1016/j.jaut.2013.08.005 (2013).
25. Chen, Q. et al. Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women? Placenta 30, 767-773, https://doi.org/10.1016/j.placenta.2009.06.008 (2009).
26. Crimi, M. & Rigolio, R. The mitochondrial genome, a growing interest inside an organelle. International journal of nanomedicine 3, 51-57 (2008).
27. Gray, M. W., Burger, G. & Lang, B. F. Mitochondrial evolution. Science 283, 1476-1481 (1999).
28. Maeda, A. & Fadeel, B. Mitochondria released by cells undergoing TNF-alpha-induced necroptosis act as danger signals. Cell death & disease 5, e1312, https://doi.org/10.1038/cddis.2014.277 (2014).
29. Sun, S. et al. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PloS one 8, e59989, https://doi.org/10.1371/journal.pone.0059989 (2013).
30. Collins, L. V., Hajizadeh, S., Holme, E., Jonsson, I. M. & Tarkowski, A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. Journal of leukocyte biology 75, 995-1000, https://doi.org/10.1189/jlb.0703328 (2004).
31. Eleftheriadis, T. et al. Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysisassociated inflammation. International urology and nephrology 46, 107-112, doi:10.1007/s11255-013-0417-z (2014).
32. Zhang, Q., Itagaki, K. & Hauser, C. J. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 34, 55-59, https://doi.org/10.1097/SHK.0b013e3181cd8c08 (2010).
33. Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107, https://doi. org/10.1038/nature08780 (2010).
34. Tong, M. et al. Placental Nano-vesicles Target to Specific Organs and Modulate Vascular Tone In Vivo. Human Reproduction 32, 2188-2198 (2017).
35. Tong, M. et al. In vivo targets of human placental micro-vesicles vary with exposure time and pregnancy. Reproduction 153, 835-845 (2017).
36. Ferrer-Oliveras, R., Llurba, E., Cabero-Roura, L. & Alijotas-Reig, J. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets. Lupus 21, 257-263, https://doi.org/10.1177/0961203311425520 (2012).
37. Birdsall, M., Pattison, N. & Chamley, L. Antiphospholipid antibodies in pregnancy. The Australian & New Zealand journal of obstetrics & gynaecology 32, 328-330 (1992).
38. Lynch, A. et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 120, 470-475 (1994).
39. Tong, M., Viall, C. A. & Chamley, L. W. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Human reproduction update 21, 97-118, https://doi.org/10.1093/humupd/dmu049 (2015).
40. Gupta, A. K. et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 26, 59-66, https://doi.org/10.1016/j.placenta.2004.04.004 (2005).
41. Gupta, A. K., Rusterholz, C., Holzgreve, W. & Hahn, S. Syncytiotrophoblast micro-particles do not induce apoptosis in peripheral T lymphocytes, but differ in their activity depending on the mode of preparation. Journal of reproductive immunology 68, 15-26, https://doi.org/10.1016/j.jri.2005.05.003 (2005).
42. Gupta, A. K., Holzgreve, W. & Hahn, S. Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Archives of gynecology and obstetrics 277, 115-119, https://doi.org/10.1007/s00404-007-0425-2 (2008).
43. Gupta, A. K. et al. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clinical chemistry 50, 2187-2190, https://doi.org/10.1373/clinchem.2004.040196 (2004).
44. Abumaree, M. H., Stone, P. R. & Chamley, L. W. Changes in the expression of apoptosis-related proteins in the life cycle of human villous trophoblast. Reproductive sciences 19, 597-606, https://doi.org/10.1177/1933719111428523 (2012).
45. Mayhew, T. M. Turnover of human villous trophoblast in normal pregnancy: what do we know and what do we need to know? Placenta 35, 229-240, https://doi.org/10.1016/j.placenta.2014.01.011 (2014).
46. Huppertz, B. et al. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Laboratory investigation; a journal of technical methods and pathology 79, 1687-1702 (1999).
47. Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual review of cell and developmental biology 30, 255-289, https://doi.org/10.1146/annurev-cellbio-101512-122326 (2014).
48. Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. The Journal of cell biology 200, 373-383, https://doi.org/10.1083/jcb.201211138 (2013).
49. Chen, Q., Guo, F., Hensby-Bennett, S., Stone, P. & Chamley, L. Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia. Placenta 33, 810-815, https://doi. org/10.1016/j.placenta.2012.07.019 (2012).
50. Chen, Q. et al. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease? Thrombosis research 114, 101-111, https://doi.org/10.1016/j. thromres.2004.04.013 (2004).
51. Chaiworapongsa, T., Chaemsaithong, P., Yeo, L. & Romero, R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nature reviews. Nephrology 10, 466-480, https://doi.org/10.1038/nrneph.2014.102 (2014).
52. Roberts, J. M. Endothelial dysfunction in preeclampsia. Seminars in reproductive endocrinology 16, 5-15, https://doi. org/10.1055/s-2007-1016248 (1998).
53. Roberts, J. M. et al. Preeclampsia: an endothelial cell disorder. American journal of obstetrics and gynecology 161, 1200-1204 (1989).
54. Goulopoulou, S., Matsumoto, T., Bomfim, G. F. & Webb, R. C. Toll-like receptor 9 activation: a novel mechanism linking placentaderived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clinical science 123, 429-435, https://doi.org/10.1042/ CS20120130 (2012).
55. McCarthy, C. M. & Kenny, L. C. Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia? American journal of reproductive immunology, https://doi.org/10.1111/aji.12526 (2016).
56. Colleoni, F. et al. Maternal blood mitochondrial DNA content during normal and intrauterine growth restricted (IUGR) pregnancy. American journal of obstetrics and gynecology 203, 365 e361-366, https://doi.org/10.1016/j.ajog.2010.05.027 (2010).
57. Lattuada, D. et al. Higher mitochondrial DNA content in human IUGR placenta. Placenta 29, 1029-1033, https://doi.org/10.1016/j. placenta.2008.09.012 (2008).
58. Prater, M. R., Johnson, V. J., Germolec, D. R., Luster, M. I. & Holladay, S. D. Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice. Vaccine 24, 263-271, https://doi. org/10.1016/j.vaccine.2005.07.105 (2006).
59. Orozco, A. F. et al. Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia. The American journal of pathology 173, 1595-1608, https://doi.org/10.2353/ajpath.2008.080414 (2008).
60. Orozco, A. F. et al. Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia. Placenta 30, 891-897, https://doi.org/10.1016/j.placenta.2009.06.012 (2009).
61. Schroeder, D. I. et al. The human placenta methylome. Proceedings of the National Academy of Sciences of the United States of America 110, 6037-6042, https://doi.org/10.1073/pnas.1215145110 (2013).
62. Hartley, J. D., Ferguson, B. J. & Moffett, A. The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia. American journal of obstetrics and gynecology 213, 268-277, https://doi.org/10.1016/j.ajog.2015.03.026 (2015).
63. Scharfe-Nugent, A. et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. Journal of immunology 188, 5706-5712, https://doi.org/10.4049/jimmunol.1103454 (2012).
64. Blair, J. D. et al. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Molecular human reproduction 19, 697-708, https://doi.org/10.1093/molehr/gat044 (2013).
65. Yuen, R. K., Penaherrera, M. S., von Dadelszen, P., McFadden, D. E. & Robinson, W. P. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. European journal of human genetics: EJHG 18, 1006-1012, https://doi.org/10.1038/ejhg.2010.63 (2010).
66. Levy, R. A. et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10, 401-404, https://doi.org/10.1191/096120301678646137 (2001).
67. Clowse, M. E., Magder, L., Witter, F. & Petri, M. Hydroxychloroquine in lupus pregnancy. Arthritis and rheumatism 54, 3640-3647, https://doi.org/10.1002/art.22159 (2006).
68. Shao, J. et al. Increased levels of HMGB1 in trophoblastic debris may contribute to preeclampsia. Reproduction 152, 775-784, https:// doi.org/10.1530/rep-16-0083 (2016).
69. Chamley, L. W., Konarkowska, B., Duncalf, A. M., Mitchell, M. D. & Johnson, P. M. Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure? Fertil Steril 76, 700-706 (2001).
70. Chamley, L. W., Duncalf, A. M., Konarkowska, B., Mitchell, M. D. & Johnson, P. M. Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies. Clin Exp Immunol 115, 571-576 (1999).
71. Viall, C. A., Chen, Q., Stone, P. R. & Chamley, L. W. Human extravillous trophoblasts bind but do not internalize antiphospholipid antibodies. Placenta 42, 9-16, https://doi.org/10.1016/j.placenta.2016.03.011 (2016).
72. Leeuwenberg, J. F. et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77, 543-549 (1992).
73. Sykes, P. J. et al. Quantitation of targets for PCR by use of limiting dilution. BioTechniques 13, 444-449 (1992).